Responses
Oral presentations: Day 1: Wednesday, September 7, 2011
Cancer 1
NMP22 as a urine-based tumour marker for bladder cancer screening in a prospective cohort of chemical workers formerly exposed to aromatic amines: results of the UroScreen study
Compose a Response to This Article
Other responses
No responses have been published for this article.